You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

NITROFURAZONE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Nitrofurazone patents expire, and when can generic versions of Nitrofurazone launch?

Nitrofurazone is a drug marketed by Ambix, Lannett, Perrigo New York, Taro, and Wendt. and is included in seven NDAs.

The generic ingredient in NITROFURAZONE is nitrofurazone. There are four drug master file entries for this compound. Additional details are available on the nitrofurazone profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for NITROFURAZONE?
  • What are the global sales for NITROFURAZONE?
  • What is Average Wholesale Price for NITROFURAZONE?
Summary for NITROFURAZONE
Drug patent expirations by year for NITROFURAZONE
Recent Clinical Trials for NITROFURAZONE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Julio RamirezEarly Phase 1
University of LouisvilleEarly Phase 1
James Graham Brown Cancer CenterEarly Phase 1

See all NITROFURAZONE clinical trials

Medical Subject Heading (MeSH) Categories for NITROFURAZONE

US Patents and Regulatory Information for NITROFURAZONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ambix NITROFURAZONE nitrofurazone OINTMENT;TOPICAL 086077-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Wendt NITROFURAZONE nitrofurazone SOLUTION;TOPICAL 087081-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Taro NITROFURAZONE nitrofurazone OINTMENT;TOPICAL 086156-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Lannett NITROFURAZONE nitrofurazone OINTMENT;TOPICAL 084393-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Perrigo New York NITROFURAZONE nitrofurazone OINTMENT;TOPICAL 084968-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.